BioSyent, Inc. (RX.V)
15.50
-0.15
(-0.96%)
CAD |
TSXV |
Mar 05, 15:59
BioSyent Market Cap : 174.57M for March 5, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arch Biopartners, Inc. | 53.55M |
| Biocure Technology, Inc. | 0.7072M |
| Resverlogix Corp. | 38.79M |
| Microbix Biosystems, Inc. | 32.56M |
| Theratechnologies, Inc. | 205.53M |
Market Cap Related Metrics
| PE Ratio | 20.58 |
| PS Ratio | 4.208 |
| PEG Ratio | 0.8187 |
| Price to Book Value | 4.375 |
| Price to Free Cash Flow | 21.97 |
| Price | 15.50 |
| Earnings Yield | 4.86% |
| PEGY Ratio | 0.7781 |
| Operating PE Ratio | 16.35 |
| Normalized PE Ratio | 20.58 |